Neuralstem Inc (NYSE MKT LLC:CUR)

4.07
Data as of Aug 29
 +0.06 / +1.50%
Today’s Change
1.59
Today|||52-Week Range
4.81
+39.86%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$353.4M

Company Description

Neuralstem, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of treatments based on human neuronal stem cells and small molecule compounds. It develops biotherapeutic products to treat and cure neurodegenerative and neurological disorders of the brain and spinal cord, including Parkinson's, Alzheimer's, stroke, multiple sclerosis, spinal cord injury and epilepsy. The company was founded by I. Richard Garr, Karl Johe and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Contact Information

Neuralstem, Inc.
20271 Goldenrod Lane
Germantown Maryland 20876
P:(301) 366-4960
Investor Relations:

Employees

Shareholders

Other institutional6.69%
Individual stakeholders6.33%
Mutual fund holders11.99%

Top Executives

Karl Y. JoheChairman & Chief Scientific Officer
I. Richard GarrPresident, CEO, CFO, Director & Legal Counsel
Thomas G. HazelSenior Vice President-Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.